70
Participants
Start Date
October 30, 2022
Primary Completion Date
May 30, 2023
Study Completion Date
November 30, 2023
Levilactobacillus brevis CNCM I-5566
Participants will take four Mucomixx tablets (containing Levilactobacillus brevis CNCM I-5566) daily for 28 days. The tablets should be taken after each of the following meals: breakfast, lunch, afternoon break, and dinner.
Placebo
Participants will take four placebo tablets daily for 28 days. The tablets should be taken after each of the following meals: breakfast, lunch, afternoon break, and dinner.
University of L'Aquila, L’Aquila
University of L'Aquila
OTHER